| Code | 0955D | ||||||||||
| MA number | 48/0088/19-S | ||||||||||
| Product Form: | cps mol 50x250 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | HRA Pharma Rare Diseases, France | ||||||||||
| Therapeutic Class: | 48 - DIAGNOSTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 21.03.2019 |
| Pediatric posology: | Yes |
| PIL: |
PIL _Metopirone_04_2022.pdf
|
| SPC: |
SPC _Metopirone_04_2022.pdf
|
| Safety feature | Yes |
| Data update: | 17.08.2023 |
